Results 91 to 100 of about 4,421 (164)

Antibody against Arenaviruses in Humans, Southwestern United States

Emerging Infectious Diseases, 2014
Mary L. Milazzo, Jon Iralu, Charles F. Fulhorst, Frederick Koster   +3 more
doaj   +1 more source

Challenges in predicting protein-protein interactions of understudied viruses: Arenavirus-human interactions. [PDF]

Comput Struct Biotechnol J
Sahni H, Crotzer SM, Moore J, Branda SS, Estrada T, Gnanakaran S.   +5 more
europepmc   +1 more source

B cell immunity to the Lassa virus glycoprotein is a correlate of vaccination-induced virus control in mice. [PDF]

Nat Commun
Abreu-Mota T, Marx AF, Winterberg D, Tintignac K, Fixemer J, Geier F, Brodmann N, Seven C, Reichmuth C, Kastner AL, Lu M, Bonilla WV, Dimitrova M, Sahin M, Zimmer G, Peipp M, Pinschewer DD.   +16 more
europepmc   +1 more source

Molecular characterization of arenavirus defective viral genomes reveals sequence features associated with their formation. [PDF]

J Virol
Hoenen T, Bohn P, Herndler S, Klamke M-N, Müller A, Groseth A.   +5 more
europepmc   +1 more source

NSs: the multifaceted bunyavirus virulence factor. [PDF]

Npj Viruses
Duboeuf M, Legrand AF, Lozach PY, Maisse C.   +3 more
europepmc   +1 more source

Development of novel monoclonal antibodies for detection of pan-Lassa virus. [PDF]

PLoS Negl Trop Dis
Paroha R, Saito T, Yamada S, Click C, Paessler S, Maruyama J.   +5 more
europepmc   +1 more source

Structure and stabilization of the antigenic glycoprotein building blocks of the New World mammarenavirus spike complex. [PDF]

mBio
Paesen GC, Ng WM, Kimuda S, Sutton G, Doores KJ, Bowden TA.   +5 more
europepmc   +2 more sources

Protocol to produce a systematic Arenavirus and Hantavirus host-pathogen database: Project ArHa. [PDF]

Wellcome Open Res
Simons D, Rivero R, Guiote AM, Gordon HLM, Milne GC, Rickard G, Redding DW, Seifert SN.   +7 more
europepmc   +1 more source

A STAT1-Knockout Mouse Model for Chapare Virus Infection and Pathogenesis. [PDF]

Viruses
Monticelli SR, Kuehne AI, Batchelor TG, Richardson JB, Lapoint Z, Williams JL, Coyne SR, Raymond JLW, Zeng X, Stefan CP, Koehler JW, Kugelman JR, Herbert AS.   +12 more
europepmc   +1 more source

Evaluating vectors for the design of a spillover-disrupting Lassa virus transmissible vaccine. [PDF]

PLoS Comput Biol
Nuismer SL, Remien CH, Ghersi B, Nichols J, Bangura J, Amara E, Kanu MC, Kanu OT, Lavalie EG, Turay M, Swaray PLK, Vandi MA, Hughes J, Feldmann H, Rosenke K, Jarvis MA, Davison AJ.   +16 more
europepmc   +1 more source